Europe Label Free Detection Market was worth USD 0.42 billion in 2018 and estimated to be growing at a CAGR of 11.17%, to reach USD 0.7 billion by 2023 Most modern biological assays work on the principle of introducing an exogenous label into a native biological system so that it can be detected as a signal to aid in the measurement of a specific aspect of the concerned biological system. Ideally, it is desirable to input minimum external agents into the biological system under study. Label-free systems have been introduced in hopes of fulfilling this requirement. The progress made by the label free detection market can be seen not only through the sales figures that speak for themselves, but they have also ushered in a new era of drug development.
The prominent features of Label Free Detection involve scientists being able to study primary cell types along with the endogenous receptors in cell lines. Both grant access to receptors in several natural states. The data gathered from Label Free Detection technologies is albeit a bit complex but provides a better reflection of the target biology. Recent advances in the label free instruments industry offer improved cost, efficiency, higher levels of sensitivity as well as sophisticated data analysis.
The advantage of implementation of label free technologies is that a plethora of cells can be used as targets for analysis. The cells aren’t genetically manipulated in any way while they perform their metabolic processes as any radioactive or fluorescent marker is absent in this mode of detection. This ensures that the response recorded by the researcher is as authentic as it can get as the cell’s physiological activity is uncontaminated. Other advantages of label free technologies include decreased costs, decreased instrument sizes as well as higher value for money capital. As for the constraints of using label free technologies, it is often regarded as a ‘black box’ technology, wherein the user finds it difficult to decode the signals. Also in the medical field, each customer is unique. LFD technology finds it difficult to understand the customers’ needs.
The Europe Label Free Detection market is broadly classified into Consumables (Biosensor Chips and Microplates) and Instruments based on product type. Furthermore, based on application they are classified into Binding Kinetics, Binding Thermodynamics, Endogenous Receptor Detection, Hit Confirmation and Lead Generation. Based on technology used, they are classified into Bio-layer Interferometry(BLI), Cellular Dielectric Spectroscopy, Optical Waveguide Grating Technology(OWG) and Surface Plasmon Resonance(SPR). Based on geography, the Europe market is divided mainly into Germany, France, U.K, Italy and Spain. The Europe market boasts the second highest market share with around 25% in addition to having a CAGR of 11.17% which is just under the global CAGR rate.
Some of the major companies dominating the market, by their products and services include Attana AB and Roche based in Switzerland. In addition to this Ametek, Inc., Bio-Rad Laboratories, Inc., BiOptix, Corning, Inc., Danaher Corporation, General Electric Corporation, Pall Corporation, PerkinElmer, all companies based in U.S, have a global presence and extend their services to the European market as well.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Technology
5.1.1 Introduction
5.1.2 Bio-layer interferometry
5.1.3 Cellular Dielectric Spectroscopy
5.1.4 Optical Waveguide Grating Technology
5.1.5 Surface Plasmon Resonance
5.1.6 Y-o-Y Growth Analysis, By Technology
5.1.7 Market Attractiveness Analysis, By Technology
5.1.8 Market Share Analysis, By Technology
5.2 Type
5.2.1 Introduction
5.2.2 Consumables
5.2.3 Instruments
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Binding Kinetics
5.3.3 Binding Thermodynamics
5.3.4 Endogenous Receptor Detection
5.3.5 Hit Confirmation
5.3.6 Lead Generation
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Type
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Ametek
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories
8.3 BiOptix
8.4 Corning
8.5 Danaher
8.6 General Electric Corporation
8.7 Pall Corporation
8.8 PerkinElmer
8.9 Attana AB
8.10 Roche
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
